Idioma:

Identification of Lynch Syndrome Among Patients With Colorectal Cancer

Moreira, Leticia ; Balaguer, Francesc ; Lindor, Noralane ; de la Chapelle, Albert ; Hampel, Heather ; Aaltonen, Lauri A ; Hopper, John L ; Le Marchand, Loic ; Gallinger, Steven ; Newcomb, Polly A ; Haile, Robert ; Thibodeau, Stephen N ; Gunawardena, Shanaka ; Jenkins, Mark A ; Buchanan, Daniel D ; Potter, John D ; Baron, John A ; Ahnen, Dennis J ; Moreno, Victor ; Andreu, Montserrat ; Ponz de Leon, Maurizio ; Rustgi, Anil K ; Castells, Antoni

JAMA : the journal of the American Medical Association, 2012-10, Vol.308 (15), p.1555-1565 [Periódico revisado por pares]

Chicago, IL: American Medical Association

Texto completo disponível

Citações Citado por

Enviar para

Título:
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Autor: Moreira, Leticia ; Balaguer, Francesc ; Lindor, Noralane ; de la Chapelle, Albert ; Hampel, Heather ; Aaltonen, Lauri A ; Hopper, John L ; Le Marchand, Loic ; Gallinger, Steven ; Newcomb, Polly A ; Haile, Robert ; Thibodeau, Stephen N ; Gunawardena, Shanaka ; Jenkins, Mark A ; Buchanan, Daniel D ; Potter, John D ; Baron, John A ; Ahnen, Dennis J ; Moreno, Victor ; Andreu, Montserrat ; Ponz de Leon, Maurizio ; Rustgi, Anil K ; Castells, Antoni
Assuntos: Adult ; Aged ; Anàlisi multivariable ; Biological and medical sciences ; Cohort Studies ; Colorectal cancer ; Colorectal Neoplasms, Hereditary Nonpolyposis - diagnosis ; Colorectal Neoplasms, Hereditary Nonpolyposis - genetics ; Càncer colorectal ; DNA Mismatch Repair - genetics ; DNA Repair Enzymes - genetics ; Family ; Female ; Finland ; Gastroenterology. Liver. Pancreas. Abdomen ; General aspects ; Genetic diseases ; Genetic disorders ; Genetic testing ; Genetic Testing - standards ; Genètica molecular ; Health risk assessment ; Humans ; Malalties hereditàries ; Male ; Medical sciences ; Middle Aged ; Molecular genetics ; Multivariate Analysis ; Mutation ; Ohio ; Registries - statistics & numerical data ; Sensitivity and Specificity ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors
É parte de: JAMA : the journal of the American Medical Association, 2012-10, Vol.308 (15), p.1555-1565
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: CONTEXT Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused by germline mutations in DNA mismatch repair (MMR) genes. Identification of gene carriers currently relies on germline analysis in patients with MMR-deficient tumors, but criteria to select individuals in whom tumor MMR testing should be performed are unclear. OBJECTIVE To establish a highly sensitive and efficient strategy for the identification of MMR gene mutation carriers among CRC probands. DESIGN, SETTING, AND PATIENTS Pooled-data analysis of 4 large cohorts of newly diagnosed CRC probands recruited between 1994 and 2010 (n = 10 206) from the Colon Cancer Family Registry, the EPICOLON project, the Ohio State University, and the University of Helsinki examining personal, tumor-related, and family characteristics, as well as microsatellite instability, tumor MMR immunostaining, and germline MMR mutational status data. MAIN OUTCOME MEASURES Performance characteristics of selected strategies (Bethesda guidelines, Jerusalem recommendations, and those derived from a bivariate/multivariate analysis of variables associated with Lynch syndrome) were compared with tumor MMR testing of all CRC patients (universal screening). RESULTS Of 10 206 informative, unrelated CRC probands, 312 (3.1%) were MMR gene mutation carriers. In the population-based cohorts (n = 3671 probands), the universal screening approach (sensitivity, 100%; 95% CI, 99.3%-100%; specificity, 93.0%; 95% CI, 92.0%-93.7%; diagnostic yield, 2.2%; 95% CI, 1.7%-2.7%) was superior to the use of Bethesda guidelines (sensitivity, 87.8%; 95% CI, 78.9%-93.2%; specificity, 97.5%; 95% CI, 96.9%-98.0%; diagnostic yield, 2.0%; 95% CI, 1.5%-2.4%; P < .001), Jerusalem recommendations (sensitivity, 85.4%; 95% CI, 77.1%-93.6%; specificity, 96.7%; 95% CI, 96.0%-97.2%; diagnostic yield, 1.9%; 95% CI, 1.4%-2.3%; P < .001), and a selective strategy based on tumor MMR testing of cases with CRC diagnosed at age 70 years or younger and in older patients fulfilling the Bethesda guidelines (sensitivity, 95.1%; 95% CI, 89.8%-99.0%; specificity, 95.5%; 95% CI, 94.7%-96.1%; diagnostic yield, 2.1%; 95% CI, 1.6%-2.6%; P < .001). This selective strategy missed 4.9% of Lynch syndrome cases but resulted in 34.8% fewer cases requiring tumor MMR testing and 28.6% fewer cases undergoing germline mutational analysis than the universal approach. CONCLUSION Universal tumor MMR testing among CRC probands had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the increase in the diagnostic yield was modest.
Editor: Chicago, IL: American Medical Association
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Identification of Lynch Syndrome Among Patients With Colorectal Cancer

Chicago, IL: American Medical Association

Buscando em bases de dados remotas. Favor aguardar.